SANDOZ FESOTERODINE FUMARATE

Identification of Sandoz Fesoterodine Fumarate

No description

Google image searchProduct monograph

Active ingredient

fesoterodine fumarate, 8 MG

DIN: 02521776

Dosage form(s): TABLET (EXTENDED-RELEASE)

Route(s) of administration: ORAL

Schedule: Prescription

Company: SANDOZ CANADA INCORPORATED

Date: 02-MAY-2022

ATC:

• G04 — UROLOGICALS (ATC, ATC/DDD, )
• G04B — OTHER UROLOGICALS, INCL. ANTISPASMODICS (ATC, ATC/DDD)
• G04BD — Urinary antispasmodics (ATC, ATC/DDD)
• G04BD11 — FESOTERODINE (ATC/DDD)

Reference brand drug: Toviaz

Pharmaceutical standard: MFR

External Links for Sandoz Fesoterodine Fumarate

Search on Google

• Sandoz Fesoterodine Fumarate side effects
• Sandoz Fesoterodine Fumarate dosage
• fesoterodine fumarate side effects
• fesoterodine fumarate dosage

Sandoz Canada Incorporated

Go to Sandoz website to see drug product details. Sometimes you can find sandoz fesoterodine fumarate photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.